NPPA decides to cap price of liquid medical oxygen & medical oxygen cylinders

▴ NPPA decides to cap price of liquid medical oxygen & medical oxygen cylinders
NPPA has decided a cap for the ex-factory price of oxygen in cylinders in order to ensure supply of oxygen cylinders from filler at reasonable prices

The present situation of COVID-19 has resulted in increased demand for Medical Oxygen (MO) in the country and hence its availability is of utmost importance. Many of the States/UTs are dependent on the medical oxygen supply from other States/UTs.

The government is committed to uninterrupted supply of Medical Oxygen especially in the times of pandemic. Oxygen Inhalation (Medicinal Gas) is a scheduled formulation, covered under the National List of Essential Medicines (NLEM). Its existing Ceiling Price fixed by NPPA is Rs. 17.49/CUM. However, due to the absence of a price cap on liquid medical oxygen, manufacturers have hiked prices to fillers. During COVID, the supply of medical oxygen through cylinders has increased. Price regulation at this end is imperative for the continued availability of medical oxygen across the country.

The issue related to availability, including pricing of oxygen has been under the continued consideration of Empowered Group 2, GOI. The Empowered Group 2 has recommended NPPA to consider capping the ex-factory price of liquid oxygen in order to ensure its supply to fillers at reasonable prices. It has also requested NPPA to consider a cap for the ex-factory price of oxygen in cylinders in order to ensure supply of oxygen cylinders from filler at reasonable prices.

National Pharmaceuticals Pricing Authority, NPPA has decided to cap the ex-factory price of Liquid Medical Oxygen at manufacturers end at Rs.15.22 paise per cubic meter exclusive of GST. The present situation of COVID-19 has resulted in increased demand for Medical Oxygen in the country. NPPA said, due to absence of price cap on liquid medical oxygen, manufacturers have hiked prices to fillers. During COVID, the supply of medical oxygen through cylinders has increased from 10 per cent to around 50 per cent of total consumption. It said price regulation at this end is imperative for the continued availability of medical oxygen across the country.

Chemicals and Fertilizers Ministry said the demand for medical oxygen has gone up almost four times, from 750 metric ton per day to 2800 metric ton per day. NPA said, to further cap the ex-factory cost of Medical Oxygen Cylinder at filler end at Rs.25.71 paise per cubic meter exclusive of GST in the suppression of the existing Ceiling Price of 17 rupees 49 paise per cubic meter for six months. The existing rate contracts of state governments for oxygen purchase, as applicable, will continue, in consumer interest. This will ensure availability of medical oxygen at consumer end at a reasonable price both at hospital level and through oxygen cylinders, especially to distant and interior districts.

Tags : #NPPA #ChemicalsandFertilizersMinistry #AvailabilityofOxygenCylinders #Pandemic

About the Author


Team Medicircle

Related Stories

Loading Please wait...
-Advertisements-


Trending Now

To stay well during festive seasonOctober 21, 2020
The fastest growing and the most awarded Cath Lab of India in 2018 is bringing affordable and accessible healthcare available for cardiovascular diseases in India saOctober 21, 2020
ViiV healthcare development program on cabotegravir and rilivirine has no pandemic interruptionsOctober 21, 2020
No significant clinical benefit with Umifenovir addition in COVID-19 treatment: Glenmark clinical study October 21, 2020
India sustains the continued trend of consistent decline in Active CasesOctober 21, 2020
Lifeness Science Institute by Luke Coutinho Introduces Programmes in Integrative Nutrition and DieteticsOctober 21, 2020
Lifeness Science Institute by Luke Coutinho Introduces Programmes in Integrative Nutrition and DieteticsOctober 21, 2020
Haryana tops Anemia Mukt Bharat Index in countryOctober 21, 2020
Covid Update: Assam & OdishaOctober 21, 2020
BriaCell announces the overall breast cancer survival (OS) data of its lead product candidate, Bria-IMT™October 21, 2020
Teladoc Health Data Shows Broadening Mental Health Care DemandOctober 21, 2020
China vaccinated 60,000 people: Result awaited October 21, 2020
Lilly hires outside advisor for COVID drug plant problemsOctober 21, 2020
No Child Mothers, Accelerating the reduction of adolescent pregnancies on occasion of Adolescent Pregnancy Prevention Week October 21, 2020
Tyber Medical receives US FDA clearance on foot and ankle plating systemsOctober 21, 2020
Green tea and coffee connected to lower death risk in people with diabetesOctober 21, 2020
MEDICAL FESTIVAL ASIA: Events for the region’s medical and healthcare sectorOctober 21, 2020
Selecta Biosciences and Asklepios BioPharmaceutical receives US FDA approval for their gene therapyOctober 21, 2020
Astellas Pharma received US FDA approval for the treatment of primary mitochondrial myopathiesOctober 21, 2020
GSK presents positive clinical data on maternal and older adults RSV candidate vaccinesOctober 21, 2020